172 related articles for article (PubMed ID: 8262049)
1. Inhibition of hematopoietic development from embryonic stem cells by antisense vav RNA.
Wulf GM; Adra CN; Lim B
EMBO J; 1993 Dec; 12(13):5065-74. PubMed ID: 8262049
[TBL] [Abstract][Full Text] [Related]
2. Hematopoietic development of vav-/- mouse embryonic stem cells.
Zhang R; Tsai FY; Orkin SH
Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12755-9. PubMed ID: 7809116
[TBL] [Abstract][Full Text] [Related]
3. A functional analysis of protooncogene Vav's role in adult human hematopoiesis.
Luger SM; Ratajczak J; Ratajczak MZ; Kuczynski WI; DiPaola RS; Ngo W; Clevenger CV; Gewirtz AM
Blood; 1996 Feb; 87(4):1326-34. PubMed ID: 8608221
[TBL] [Abstract][Full Text] [Related]
4. The hematopoietically expressed vav proto-oncogene shares homology with the dbl GDP-GTP exchange factor, the bcr gene and a yeast gene (CDC24) involved in cytoskeletal organization.
Adams JM; Houston H; Allen J; Lints T; Harvey R
Oncogene; 1992 Apr; 7(4):611-8. PubMed ID: 1565462
[TBL] [Abstract][Full Text] [Related]
5. The vav proto-oncogene is required early in embryogenesis but not for hematopoietic development in vitro.
Zmuidzinas A; Fischer KD; Lira SA; Forrester L; Bryant S; Bernstein A; Barbacid M
EMBO J; 1995 Jan; 14(1):1-11. PubMed ID: 7828581
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of the zinc finger protein MZF1 inhibits hematopoietic development from embryonic stem cells: correlation with negative regulation of CD34 and c-myb promoter activity.
Perrotti D; Melotti P; Skorski T; Casella I; Peschle C; Calabretta B
Mol Cell Biol; 1995 Nov; 15(11):6075-87. PubMed ID: 7565760
[TBL] [Abstract][Full Text] [Related]
7. Vav: Captain Hook for signal transduction?
Katzav S
Crit Rev Oncog; 1995; 6(2):87-97. PubMed ID: 8792085
[TBL] [Abstract][Full Text] [Related]
8. vav, a novel human oncogene derived from a locus ubiquitously expressed in hematopoietic cells.
Katzav S; Martin-Zanca D; Barbacid M
EMBO J; 1989 Aug; 8(8):2283-90. PubMed ID: 2477241
[TBL] [Abstract][Full Text] [Related]
9. Loss of the amino-terminal helix-loop-helix domain of the vav proto-oncogene activates its transforming potential.
Katzav S; Cleveland JL; Heslop HE; Pulido D
Mol Cell Biol; 1991 Apr; 11(4):1912-20. PubMed ID: 2005887
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of activation of the vav protooncogene.
Coppola J; Bryant S; Koda T; Conway D; Barbacid M
Cell Growth Differ; 1991 Feb; 2(2):95-105. PubMed ID: 2069873
[TBL] [Abstract][Full Text] [Related]
11. Single point mutations in the SH2 domain impair the transforming potential of vav and fail to activate proto-vav.
Katzav S
Oncogene; 1993 Jul; 8(7):1757-63. PubMed ID: 8510922
[TBL] [Abstract][Full Text] [Related]
12. Constitutive Bcl-2 expression throughout the hematopoietic compartment affects multiple lineages and enhances progenitor cell survival.
Ogilvy S; Metcalf D; Print CG; Bath ML; Harris AW; Adams JM
Proc Natl Acad Sci U S A; 1999 Dec; 96(26):14943-8. PubMed ID: 10611317
[TBL] [Abstract][Full Text] [Related]
13. PU.1 regulates the expression of the vav proto-oncogene.
Denkinger DJ; Lambrecht TQ; Cushman-Vokoun AM; Kawahara RS
J Cell Biochem; 2002; 84(4):772-83. PubMed ID: 11835402
[TBL] [Abstract][Full Text] [Related]
14. Expression of vav proto-oncogene by nonhematopoietic trophoblast cells at the human uteroplacental interface.
Higuchi T; Kanzaki H; Fujimoto M; Hatayama H; Watanabe H; Fukumoto M; Kaneko Y; Higashitsuji H; Kishishita M; Mori T
Biol Reprod; 1995 Oct; 53(4):840-6. PubMed ID: 8547479
[TBL] [Abstract][Full Text] [Related]
15. Induction of hematopoietic commitment and erythromyeloid differentiation in embryonal stem cells constitutively expressing c-myb.
Melotti P; Calabretta B
Blood; 1996 Mar; 87(6):2221-34. PubMed ID: 8630382
[TBL] [Abstract][Full Text] [Related]
16. Expression of a novel isoform of Vav, Vav-T, containing a single Src homology 3 domain in murine testicular germ cells.
Okumura K; Kaneko Y; Nonoguchi K; Nishiyama H; Yokoi H; Higuchi T; Itoh K; Yoshida O; Miki T; Fujita J
Oncogene; 1997 Feb; 14(6):713-20. PubMed ID: 9038379
[TBL] [Abstract][Full Text] [Related]
17. Proto-oncogene products Vav and c-Cbl are involved in the signal transduction through Grb2/Ash in hematopoietic cells.
Hanazono Y; Odai H; Sasaki K; Iwamatsu A; Yazaki Y; Hirai H
Acta Haematol; 1996; 95(3-4):236-42. PubMed ID: 8677749
[TBL] [Abstract][Full Text] [Related]
18. Major transcript variants of VAV3, a new member of the VAV family of guanine nucleotide exchange factors.
Trenkle T; McClelland M; Adlkofer K; Welsh J
Gene; 2000 Mar; 245(1):139-49. PubMed ID: 10713454
[TBL] [Abstract][Full Text] [Related]
19. Vav: function and regulation in hematopoietic cell signaling.
Bonnefoy-Bérard N; Munshi A; Yron I; Wu S; Collins TL; Deckert M; Shalom-Barak T; Giampa L; Herbert E; Hernandez J; Meller N; Couture C; Altman A
Stem Cells; 1996 May; 14(3):250-68. PubMed ID: 8724692
[TBL] [Abstract][Full Text] [Related]
20. Stage-related proliferative activity determines c-myb functional requirements during normal human hematopoiesis.
Caracciolo D; Venturelli D; Valtieri M; Peschle C; Gewirtz AM; Calabretta B
J Clin Invest; 1990 Jan; 85(1):55-61. PubMed ID: 2404028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
